MRK vs PAHC · P/E 33, rev $16.61B vs P/E 13, rev $1.52B
Merck & Company Inc (MRK) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the MRK and PAHC stock pages for the full models.
Not investment advice.